tirzepatide vs semaglutide risks 2026: 22% vs 15% Weight Loss Guide Semaglutide vs Tirzepatide Side Effects:

No differences were observed in systolic blood pressure (SBP) or medical therapy for HF, except that patients with lower obesity class were more likely to be treated with sodium-glucose co-transporter-2 (SGLT2) inhibitors, and patients with higher obesity class were more likely to receive loop diuretics at higher dose

The agency has specifically warned against using salt forms of semaglutide

Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome

Furthermore, SGLT2i outperforms metformin in lowering body weight and FPG levels

Individualize the dosage of JANUMET on the basis of the patients current regimen, effectiveness, and tolerability

Lower Thirst Signals Some patients report feeling not thirsty even when dehydrated